The worldwide market is moving toward serum-free, chemically defined media and high-efficiency transfection systems that improve reproducibility. Mammalian expression platforms lead because they support correct folding of complex proteins. Pharmaceutical companies, academic labs, and CROs drive demand. Regulatory expectations and manufacturing scalability continue to shape adoption.
According...
Portuguese (Brazil)
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek